Vanda Pharmaceuticals (VNDA) Retained Earnings (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Retained Earnings of $212000.0 in Q1 2026, down 66.3% quarter-over-quarter from $629000.0 in Q4 2025, and down 44.65% year-over-year from $383000.0 in Q1 2025.
Vanda Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at $212000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 44.65% year-over-year to $212000.0; the TTM figure through Mar 2026 stood at $212000.0 (down 44.65% YoY), while the FY2025 annual figure was $629000.0, up 750.0% from the prior year.
- Retained Earnings came in at $212000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $629000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $702000.0 in Q3 2024 to a low of -$159.5 million in Q1 2024.
- A 5-year average of -$18.6 million and a median of -$255000.0 in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 62463.92% in 2024 and soared 750.0% in 2025, its largest moves.
- Vanda Pharmaceuticals' Retained Earnings stood at -$1.2 million in 2022, then surged by 97.49% to -$30000.0 in 2023, then jumped by 346.67% to $74000.0 in 2024, then jumped by 750.0% to $629000.0 in 2025, then slumped by 66.3% to $212000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $212000.0, $629000.0, and $540000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 629,000.00 |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 702,000.00 |
| Jun 30, 2024 | -330,000.00 |
| Mar 31, 2024 | -159.54 Mn |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -152.99 Mn |
| Jun 30, 2023 | -865,000.00 |
| Mar 31, 2023 | -255,000.00 |
| Dec 31, 2022 | -1.19 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -1.43 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -175,000.00 |
| Sep 30, 2021 | -171.25 Mn |
| Jun 30, 2021 | -179.03 Mn |
| Mar 31, 2021 | -188.68 Mn |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | -205.52 Mn |
| Jun 30, 2020 | -211.47 Mn |
| Mar 31, 2020 | 781,000.00 |
| Dec 31, 2019 | 249,000.00 |
| Sep 30, 2019 | 211,000.00 |
| Jun 30, 2019 | 386,000.00 |
| Mar 31, 2019 | 135,000.00 |
| Dec 31, 2018 | 1,000.00 |
| Sep 30, 2018 | -346.58 Mn |
| Jun 30, 2018 | 79,000.00 |
| Mar 31, 2018 | -28,000.00 |
| Dec 31, 2017 | -34,000.00 |
| Sep 30, 2017 | -359.59 Mn |
| Jun 30, 2017 | 11,000.00 |
| Mar 31, 2017 | -353.50 Mn |
| Dec 31, 2016 | 58,000.00 |
| Sep 30, 2016 | 142,000.00 |
| Jun 30, 2016 | -344.83 Mn |
| Mar 31, 2016 | 92,000.00 |
| Dec 31, 2015 | -327.85 Mn |
| Sep 30, 2015 | -313.05 Mn |
| Jun 30, 2015 | -303.59 Mn |
| Mar 31, 2015 | -298.21 Mn |
| Dec 31, 2014 | -287.98 Mn |
| Sep 30, 2014 | -357.70 Mn |
| Jun 30, 2014 | -356.28 Mn |
| Mar 31, 2014 | -334.70 Mn |
| Dec 31, 2013 | -308.17 Mn |
| Sep 30, 2013 | -303.74 Mn |
| Jun 30, 2013 | -298.36 Mn |
| Mar 31, 2013 | -295.28 Mn |
| Dec 31, 2012 | -291.11 Mn |
| Sep 30, 2012 | 23,000.00 |
| Jun 30, 2012 | -279.41 Mn |
| Mar 31, 2012 | -271.41 Mn |
| Dec 31, 2011 | -263.44 Mn |
| Sep 30, 2011 | -257.92 Mn |
| Jun 30, 2011 | 85,000.00 |
| Dec 31, 2010 | -253.64 Mn |